Lataa...
Endocannabinoids and the gastrointestinal tract: what are the key questions?
Cannabinoid (CB(1)) receptor activation acts neuronally, reducing GI motility, diarrhoea, pain, transient lower oesophageal sphincter relaxations (TLESRs) and emesis, and promoting eating. CB(2) receptor activation acts mostly via immune cells to reduce inflammation. What are the key questions which...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group
2007
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2190011/ https://ncbi.nlm.nih.gov/pubmed/17767170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0707422 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|